Cite

HARVARD Citation

    Delluc, A. et al. (2008). Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome. Annals of the rheumatic diseases. 67 (2), pp. 278-279. [Online]. 
  
Back to record